-
HORIZON PHARMA IRELAND LIMITED et al v. ACTAVIS LABORATORIES UT, INC. et al DC CAFC
- 1:15-cv-07742
- D.N.J.
- Judge: Noel L. Hillman
+1
- Filed: 10/27/2015
- Closed: 05/23/2017
- Latest Docket Entry: 03/03/2020
- PACER
3
Plaintiffs
3
Defendants
1
Accused
Product
2
Patents-in-Suit
575
Days in
Litigation
-
HORIZON PHARMA IRELAND LIMITED et al v. ACTAVIS LABORATORIES UT, INC. et al DC CAFC
- 1:15-cv-07742
- D.N.J.
- Judge: Noel L. Hillman
+1
- Filed: 10/27/2015
- Closed: 05/23/2017
- Latest Docket Entry: 03/03/2020
- PACER
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
2 |
The topical formulation of claim 1, wherein the formulation consists essentially of: 30-60% w/w of DMSO; 1-15% w/w of propylene glycol; 1-30% w/w of ethanol; optionally glycerine; water; and at least one thickening agent selected from the group
view more
|
Invalid
Entry 85 |
3 |
The topical formulation of claim 2, wherein the concentration of DMSO is about 40% to about 50% w/w.
|
Invalid
Entry 85 |
4 |
The topical formulation of claim 3, wherein the concentration of DMSO is a member selected from the group consisting of 40%, 41%, 42%, 43%, 445%, 46%, 47%, 48%, 49% and 50% w/w, and all fractions in between.
|
Invalid
Entry 85 |
5 |
The topical formulation of claim 2, wherein the concentration of ethanol is present at 23-29% w/w.
|
Invalid
Entry 85 |
8 |
The topical formulation of claim 2, wherein the at least one thickening agent is selected from the group consisting of a cellulose polymer, a cellulose derivative, and mixtures thereof.
|
Invalid
Entry 85 |
9 |
The topical formulation of claim 8, wherein the at least one thickening agent is hydroxypropyl cellulose.
|
Invalid
Entry 85 |
10 |
The topical formulation of claim 2, wherein the formulation consists essentially of: 2% w/w diclofenac sodium; 40-50% w/w of DMSO; 23-29% w/w of ethanol; hydroxypropyl cellulose; water: and 10-12% w/w of propylene glycol.
|
Invalid
Entry 85 |
11 |
The topical formulation of claim 10, wherein the concentration of DMSO is a member selected from the group consisting of 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49% and 50% w/w, and all fractions in between.
|
Invalid
Entry 85 |
Claim # | Claim Text | Outcome |
---|---|---|
2 |
The method of claim 1, wherein the formulation consists essentially of: 30-60% w/w of DMSO; 1-15% w/w of propylene glycol; 1-30% w/w of ethanol; optionally glycerine; water; and at least one thickening agent selected from the group consisting of a
view more
|
Invalid
Entry 85 |
3 |
The method of claim 2, wherein the concentration of DMSO is about 40% to about 50% w/w.
|
Invalid
Entry 85 |
4 |
The method of claim 3, wherein the concentration of DMSO is a member selected from the group consisting of 40%, 41%, 42%, 43%, 445%, 46%, 47%, 48%, 49% and 50% w/w, and all fractions in between.
|
Invalid
Entry 85 |
5 |
The method of claim 2, wherein the concentration of ethanol is present at 23-29% w/w.
|
Invalid
Entry 85 |
9 |
The method of claim 2, wherein the at least one thickening agent is selected from the group consisting of a cellulose polymer, a cellulose derivative, and mixtures thereof.
|
Invalid
Entry 85 |
10 |
The method of claim 9, wherein the at least one thickening agent is hydroxypropyl cellulose.
|
Invalid
Entry 85 |
11 |
The method of claim 10, wherein the formulation consists essentially of comprises: 2% w/w diclofenac sodium; 40-50% w/w of DMSO; 23-29% w/w of ethanol; hydroxypropyl cellulose; water: and 10-12% w/w of propylene glycol.
|
Invalid
Entry 85 |
12 |
The method of claim 11, wherein the concentration of DMSO is a member selected from the group consisting of 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49% and 50% w/w, and all fractions in between.
|
Invalid
Entry 85 |